Miyamura K, Takeyama K, Kojima S, Minami S, Matsuyama K, Morishima Y, Kodera Y
Department of Internal Medicine, Children's Medical Center, Japanese Red Cross Nagoya First Hospital.
Bone Marrow Transplant. 1989 Sep;4(5):533-5.
We studied a total of 50 recipients who had received allogeneic bone marrow transplantation (BMT) and evaluated both the presence of hemorrhagic cystitis (HC) and the urinary excretion of adenovirus. Twelve recipients developed HC and eight of these 12 patients excreted adenovirus type 11 at the onset of cystitis. Urine for virus isolation was attempted 30, 60 and 100 days after BMT. Among 137 specimens examined, eight were positive for adenovirus type 11. Of these eight samples, six were collected during HC; while in the 129 samples which were negative for adenovirus, only three specimens was collected during HC. Female patients, seropositivity for the antibody to adenovirus prior to BMT and acute graft-versus-host disease (grade 2-4) showed a significant impact on the risk of adenovirus HC. It may be said that adenovirus type 11 is one of the causative agents of HC in BMT recipients.
我们共研究了50例接受同种异体骨髓移植(BMT)的受者,评估了出血性膀胱炎(HC)的发生情况以及腺病毒的尿排泄情况。12例受者发生了HC,其中8例在膀胱炎发作时排泄出11型腺病毒。在BMT后30、60和100天尝试进行病毒分离的尿液检测。在137份检测标本中,8份11型腺病毒呈阳性。在这8份样本中,6份是在HC期间采集的;而在129份腺病毒阴性的样本中,只有3份标本是在HC期间采集的。女性患者、BMT前腺病毒抗体血清阳性以及急性移植物抗宿主病(2 - 4级)对腺病毒HC的风险有显著影响。可以说,11型腺病毒是BMT受者中HC的致病因素之一。